Breaking News on Global Pharmaceutical Technology & Manufacturing

Hot Topics > Lifecycle management

Lifecycle management

As R&D productivity declines and the age of blockbuster medicines reaches an end, the pharmaceutical industry is looking at ways to extend the profitable life of its products up to and beyond patent expiry.

Critical gains funding for hGH nasal delivery

19-Oct-2009 - Critical Pharmaceuticals has received a £1.5m ($2.4m) award to develop its hGH nasal spray, the market for which could be sizeable as company’s attempt to differentiate in response to generic...

ACRO wants trials for most biosimilars

15-Oct-2009 - ACRO says while a 12-year exclusivity period for innovative drugs is important for R&D, US legislation should include rules on trials for biosimilars

Stralfors says pack service plan can help drugmakers hit deadlines

15-Oct-2009 - Packaging group Stralfors says its recent collaboration with Novo Nordisk proves that its service plan is ideal for projects with strict time-to-market requirements.

CPhI 2009 show preview

08-Oct-2009 - We look ahead to CPhI 2009 which takes place in Madrid, Spain next week and will showcase the world’s leading ingredients, contract services, machinery and biotech companies.

Labopharm upbeat about depression drug after FDA OKs API maker

08-Oct-2009 - Canadian drugmaker Labopharm says its Italian API maker Gruppo Angelini has resolved all the US FDA concerns about processes used to make a once-a day version of the depression drug...

Genentech licenses SurModics tech for SR Lucentis

07-Oct-2009 - Its new microparticle technology licensing deal with Genentech could be worth as much as $200m (€136m) says US delivery specialist SurModics.

News in brief

Sanofi, Teva and Ratiopharm raided in EC competition probe

07-Oct-2009 - French drug major Sanofi Aventis, Israel's Teva Pharmaceutical Industries and Germany’s Ratiopharm were raided by European Commission (EC) competition officials yesterday as part of an ongoing investigation.

French govt unlikey to relinquish grip on health spending, says BMI

06-Oct-2009 - Despite the government’s “aggressive” promotion of generic drugs, pharmaceutical spending in France will continue to grow, according to new analysis by Business Monitor International (BMI).

Hospira buys facility & filgrastim rights to boost biogenerics

06-Oct-2009 - Hospira has acquired the worldwide rights to filgrastim and a Croatian biologics plant from Pliva, increasing its presence in the biogenerics field, and told in-PharmaTechnologist that further expansions are possible.

FDA proposes cGMP rule for combination products

29-Sep-2009 - The FDA is to establish current good manufacturing practice (cGMP) requirements for combination products to eliminate inconsistencies that could affect product safety and public health.

Controlled-release can deliver for generics firms, says Espicom

03-Sep-2009 - Wyeth’s battles to protect the controlled-release (CR) version of its anti-depressant Effexor are a sign of things to come according to a new Espicom report identifying 30 CR drugs likely...

Biosimilars market to be worth $19.4bn by 2014

03-Sep-2009 - The biosimilars sector is predicted to be worth $19.4bn (€13.6bn) by 2014, by which time the US will have overtaken Asia as the dominant market, according to a report.

Pfizer inaugurates new $214m Swedish biotech plant

26-Aug-2009 - Pfizer’s new $214.8 million (€150m) biotechnology facility in Strangnas, Sweden was inaugurated yesterday, securing the country’s future in the company’s manufacturing network according to global manufacturing president Natale Ricciardi....

Microneedle patch could boost compliance

24-Aug-2009 - Researchers have presented new microneedle drug delivery patches, which, using technology developed in the electronics sector, could improve compliance and treat ocular diseases.

Eastern Europe drug market worth $41bn by 2014; but rules complex

19-Aug-2009 - Eastern Europe’s pharmaceutical market is growing at an impressive rate, but the complex regulatory rules being introduced may make it a less attractive proposition that it first appears, according to...

West’s operating income drops in Q2

05-Aug-2009 - West Pharmaceutical Services’ operating income fell by 33 per cent in Q2 but the company reported that demand for some of its drug delivery technology is strong.

Positive Phase II for intranasal antiemetic

04-Aug-2009 - Shin Nippon Biomedical Laboratories (SNBL) has posted a positive first report on the Phase II trial of its intranasal antiemetic, which it claims is a more convenient treatment for cancer...

BioMarin: good news on Kuvan patents; bad news as costs hit Q2 profits

03-Aug-2009 - New US patents for the PKU drug Kuvan will “significantly strengthen” BioMarin’s position according to CEO Jean-Jacques Bienaime.

Medingo’s insulin patch approved; shares rocket

30-Jul-2009 - Medingo’s insulin dispensing patch has been approved by the US Food and Drug Administration (FDA), sending shares in its parent company soaring to a 12 month high.

News in brief

Wyeth shareholders OK Pfizer takeover

21-Jul-2009 -  Wyeth’s shareholders gave Pfizer’s $68bn (€48bn) takeover a ringing endorsement late yesterday, with 98 per cent voting in favour of the deal.

Pfizer may bid for Turkey’s Abdi Ibrahim

20-Jul-2009 -  Rumours suggest that US drug giant Pfizer is considering a bid for Turkish generics group Abdi Ibrahim as part of its strategy of expanding in emerging markets.

Pfizer plans Irish process lab, shelves SF unit and sells skin drugs to Graceway

07-Jul-2009 -  Pfizer will invest €11m ($15.3m) in a new kilo technology R&D laboratory at its API manufacturing facility in Ringaskiddy, Ireland.

News in brief

GSK buys 13 B-MS generics for North African market

06-Jul-2009 -  UK drug major GSK has paid Bristol-Myers Squibb’s (BSM) $23.2m (€16.6m) for 13 generic products that it sells in North Africa and the Middle East.

Mylan partners to create FOBs

30-Jun-2009 -  Mylan has followed Teva’s lead by partnering to develop follow-on biologics (FOB), with the Indian generic maker regarding Biocon as the “ideal partner” to help it enter the market. ...

Bio drugs to dominate top ten list by 2014

18-Jun-2009 - Seven of the top ten drugs will be biopharmaceuticals by 2014 according to sector analysts Evaluate Pharma.

Key Industry Events

 

Access all events listing

Our events, Events from partners...